Protease Inhibitors in AIDS Therapy (Infectious Disease and Therapy)

C. T. Baker: Medicinal Chemistry, Vertex Pharmaceuticals, Cambridge, Massachusetts J. S. Boger: Vertex Pharmaceuticals, Cambridge, Massachusetts S. P. Chambers: Vertex Pharmaceuticals, Cambridge, Massachusetts R. Alan Chrusciel, Ph.D.: Structural, Analytical, and Medicinal Chemistry Research, Pharmacia and Upjohn, Kalamazoo, Michigan D. D. Deininger: Vertex Pharmaceuticals, Cambridge, Massachusetts Bruce D. Dorsey, Ph.D.: Medicinal Chemistry, Merck Research Laboratories, West Point, Pennsylvania Ian B. Duncan, Ph.D.: Roche Discovery Welwyn, Welwyn Garden City, Hertfordshire, England M. Dwyer: Vertex Pharmaceuticals, Cambridge, Massachusetts L. Elsayed: Vertex Pharmaceuticals, Cambridge, Massachusetts John W. Erickson, Ph.D.: Director, Tibotec Institute for Therapeutics Research, Tibotec, Inc., Rockville, Maryland Charles W. Flexner, M.D.: Departments of Medicine, Pharmacology and Molecular Sciences, and International Health, The Johns Hopkins University School of Medicine, and School of Hygiene and Public Health, Baltimore, Maryland J. Fulghum: Vertex Pharmaceuticals, Cambridge, Massachusetts Marshall J. Glesby, M.D., Ph.D.: Department of Medicine, Weill Medical College of Cornell University, New York, New York Roy M. Gulick, M.D., M.P.H.: Department of Medicine, Weill Medical College of Cornell University, New York, New York Dale J. Kempf: Pharmaceutical Products Division, Abbott Laboratories, Abbott Park, Illinois E. E. Kim: Vertex Pharmaceuticals, Cambridge, Massachusetts Daniel R. Kuritzkes, M.D.: Division of Infectious Diseases, University of Colorado Health Sciences Center, Denver, Colorado B. Li: Vertex Pharmaceuticals, Cambridge, Massachusetts D. J. Livingston: Vertex Pharmaceuticals, Cambridge, Massachusetts M. A. Murcko: Vertex Pharmaceuticals, Cambridge, Massachusetts Jeffrey Murray: Division of Antiviral Drug Products, U.S. Food and Drug Administration, Rockville, Maryland M. A. Navia: Vertex Pharmaceuticals, Cambridge, Massachusetts Judith A. Nicholas, Ph.D.: Drug Discovery, MDS Pharma Services, Bothell, Washington P. Novak: Vertex Pharmaceuticals, Cambridge, Massachusetts Richard C. Ogden: Agouron Pharmaceuticals, San Diego, California S. Pazhanisamy, Ph.D.: Vertex Pharmaceuticals, Cambridge, Massachusetts B. G. Rao, Ph.D.: Vertex Pharmaceuticals, Cambridge, Massachusetts Sally Redshaw, Ph.D.: Department of Medicinal Chemistry, Roche Discovery Welwyn, Welwyn Garden City, Hertfordshire, England Siegfried H. Reich, Ph.D.: Department of Medicinal Chemistry, Agouron Pharmaceuticals, San Diego, California C. Stuver: Vertex Pharmaceuticals, Cambridge, Massachusetts Suvit Thaisrivongs, Ph.D.: Structural, Analytical, and Medicinal Chemistry Research, Pharmacia and Upjohn, Kalamazoo, Michigan J. A. Thomson: Vertex Pharmaceuticals, Cambridge, Massachusetts R. D. Tung: Vertex Pharmaceuticals, Cambridge, Massachusetts Joseph P. Vacca, Ph.D.: Department of Medicinal Chemistry, Merck Research Laboratories, West Point, Pennsylvania Benjamin Young, M.D., Ph.D.: Rose Medical Center, and Division of Infectious Diseases, University of Colorado Health Sciences Center, Denver, ColoradoRichard C. Ogden is the author of 'Protease Inhibitors in AIDS Therapy (Infectious Disease and Therapy)', published 2001 under ISBN 9780824704612 and ISBN 0824704614.